<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">P Van der Linden</style></author><author><style face="normal" font="default" size="100%">M Lambermont</style></author><author><style face="normal" font="default" size="100%">AM. Dierick</style></author><author><style face="normal" font="default" size="100%">R Hübner</style></author><author><style face="normal" font="default" size="100%">Y Benoit</style></author><author><style face="normal" font="default" size="100%">D De Backer</style></author><author><style face="normal" font="default" size="100%">R De Paep</style></author><author><style face="normal" font="default" size="100%">A Ferrant</style></author><author><style face="normal" font="default" size="100%">Latinne, D</style></author><author><style face="normal" font="default" size="100%">L Muylle</style></author><author><style face="normal" font="default" size="100%">D Selleslag</style></author><author><style face="normal" font="default" size="100%">B Szabo</style></author><author><style face="normal" font="default" size="100%">Isabelle Thomas</style></author><author><style face="normal" font="default" size="100%">Vandekerckhove,B.</style></author><author><style face="normal" font="default" size="100%">V Deneys</style></author></authors><translated-authors><author><style face="normal" font="default" size="100%">Working Group of the Superior Health Council</style></author></translated-authors></contributors><titles><title><style face="normal" font="default" size="100%">Recommendations in the event of a suspected transfusion-related acute lung injury (TRALI).</style></title><secondary-title><style face="normal" font="default" size="100%">Acta Clin Belg</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Acute Lung Injury</style></keyword><keyword><style  face="normal" font="default" size="100%">Antibodies, Antineutrophil Cytoplasmic</style></keyword><keyword><style  face="normal" font="default" size="100%">Autoantibodies</style></keyword><keyword><style  face="normal" font="default" size="100%">Belgium</style></keyword><keyword><style  face="normal" font="default" size="100%">Blood Donors</style></keyword><keyword><style  face="normal" font="default" size="100%">Diagnosis, Differential</style></keyword><keyword><style  face="normal" font="default" size="100%">HLA Antigens</style></keyword><keyword><style  face="normal" font="default" size="100%">Humans</style></keyword><keyword><style  face="normal" font="default" size="100%">Oxygen Inhalation Therapy</style></keyword><keyword><style  face="normal" font="default" size="100%">Positive-Pressure Respiration</style></keyword><keyword><style  face="normal" font="default" size="100%">Respiratory Distress Syndrome, Adult</style></keyword><keyword><style  face="normal" font="default" size="100%">Transfusion Reaction</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2012</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2012 May-Jun</style></date></pub-dates></dates><number><style face="normal" font="default" size="100%">208</style></number><volume><style face="normal" font="default" size="100%">67</style></volume><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p&gt;The following recommendations, which aim at improving the clinical diagnosis ofTRALI and the laboratory investigations that can support it, were drawn up by a working group of the Superior Health Council. TRALI is a complication of blood transfusion that is both serious and underreported. Systematic reporting may help to develop preventive actions. Therefore, the Superior Health Council recommends that there should be a more stringent surveillance of patients who receive a blood component transfusion. The clinician should pay very close attention to any change in the patient's respiratory status (cf. dyspnoea and arterial desaturation), which should be notified systematically to the haemovigilance contact person in the hospital.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">3</style></issue><section><style face="normal" font="default" size="100%">201</style></section></record></records></xml>